SEC Form 4 · accession 0001209191-15-068604
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick G Enright
Director
Period of report
Aug 27, 2015
Accepted (ET)
Aug 31, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 27, 2015 | S | 425 | $167.87 | D | 1,734 | D | |
| Ordinary SharesF1 | holding | — | — | — | 274,500 | I | By Longitude Venture Partners, L.P. | |
| Ordinary SharesF1 | holding | — | — | — | 5,500 | I | By Longitude Capital Associates, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.
Remarks
All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.